Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec;23(8):1188-1211.
doi: 10.1111/pedi.13426.

ISPAD Clinical Practice Consensus Guidelines 2022: The diagnosis and management of monogenic diabetes in children and adolescents

Affiliations

ISPAD Clinical Practice Consensus Guidelines 2022: The diagnosis and management of monogenic diabetes in children and adolescents

Siri Atma W Greeley et al. Pediatr Diabetes. 2022 Dec.
No abstract available

Keywords: MODY; diabetes mellitus classification; genetics; monogenic; neonatal diabetes.

PubMed Disclaimer

Conflict of interest statement

Dr Michel Polak MD, PhD has acted as scientific advisor for the development of the glibenclamide‐glyburide suspension named AMGLIDIA in the European Union. The other authors have declared no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Insulin secretion from the pancreatic beta cell in (A) normal cell in a high plasma glucose environment and (B) in a cell with a K‐ATP channel mutation. Source: adapted from Reference . (A) Glucose enters the cell and is metabolized, causing an increase in ATP, K‐ATP channel closure is induced via ATP binding, the membrane is depolarized, and calcium influx is triggered resulting in the release of insulin from its storage vesicles. (B) A gain of function mutation in the K‐ATP channel results in the failure of ATP to bind to the channel, causing the channel to remain open, the membrane stays hyperpolarized and no insulin is released

Similar articles

Cited by

References

    1. Murphy R, Ellard S, Hattersley AT. Clinical implications of a molecular genetic classification of monogenic beta‐cell diabetes. Nat Clin Pract Endocrinol Metab. 2008;4(4):200‐213. doi:10.1038/ncpendmet0778 - DOI - PubMed
    1. Greeley SA, John PM, Winn AN, et al. The cost‐effectiveness of personalized genetic medicine: the case of genetic testing in neonatal diabetes. Diabetes Care. 2011;34(3):622‐627. doi:10.2337/dc10-1616 - DOI - PMC - PubMed
    1. Naylor RN, John PM, Winn AN, et al. Cost‐effectiveness of MODY genetic testing: translating genomic advances into practical health applications. Diabetes Care. 2014;37(1):202‐209. doi:10.2337/dc13-0410 - DOI - PMC - PubMed
    1. Bonnefond A, Philippe J, Durand E, et al. Highly sensitive diagnosis of 43 monogenic forms of diabetes or obesity through one‐step PCR‐based enrichment in combination with next‐generation sequencing. Diabetes Care. 2014;37(2):460‐467. doi:10.2337/dc13-0698 - DOI - PubMed
    1. Ellard S, Lango Allen H, De Franco E, et al. Improved genetic testing for monogenic diabetes using targeted next‐generation sequencing. Diabetologia. 2013;56(9):1958‐1963. doi:10.1007/s00125-013-2962-5 - DOI - PMC - PubMed